Discovery of an Oral, Beyond-Rule-of-Five Mcl-1 Protein–Protein Interaction Modulator with the Potential of Treating Hematological Malignancies-Reference-Cited by-同舟云学术

Discovery of an Oral, Beyond-Rule-of-Five Mcl-1 Protein–Protein Interaction Modulator with the Potential of Treating Hematological Malignancies

Published:2023-04-28 Issue:9 Volume:66 Page:6122-6148
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Romanov-Michailidis Fedor¹^ORCID,Hsiao Chien-Chi¹,Urner Lorenz M.¹,Jerhaoui Soufyan¹,Surkyn Michel¹,Miller Bradley²,Vos Ann¹,Dominguez Blanco Maria¹,Bueters Ruud¹,Vinken Petra¹,Bekkers Mariette¹,Walker David²^ORCID,Pietrak Beth²,Eyckmans Werner¹,Dores-Sousa José Luís¹,Joo Koo Seong¹,Lento William²,Bauser Marcus¹,Philippar Ulrike¹,Rombouts Frederik J. R.¹

Affiliation:

1. Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium

2. Janssen Research & Development LLC, 1400 McKean Road, Spring House, Pennsylvania 19477, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c01953

Reference98 articles.

1. Cell Death Signaling

2. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins